Signify Health (SGFY) Set to Announce Earnings on Wednesday

Signify Health (NYSE:SGFYGet Rating) is scheduled to be posting its quarterly earnings results after the market closes on Wednesday, May 4th. Analysts expect Signify Health to post earnings of $0.03 per share for the quarter. Signify Health has set its FY 2022 guidance at EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.

Signify Health (NYSE:SGFYGet Rating) last announced its quarterly earnings data on Wednesday, March 2nd. The company reported $0.01 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.01). The firm had revenue of $181.40 million for the quarter, compared to analyst estimates of $173.26 million. Signify Health had a return on equity of 4.36% and a net margin of 2.55%. The company’s revenue for the quarter was down 6.3% compared to the same quarter last year. On average, analysts expect Signify Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Signify Health stock opened at $14.83 on Wednesday. The company has a market capitalization of $2.54 billion, a price-to-earnings ratio of 134.83 and a beta of 1.31. The company has a quick ratio of 5.46, a current ratio of 5.46 and a debt-to-equity ratio of 0.22. Signify Health has a 12-month low of $11.11 and a 12-month high of $31.91. The firm’s 50-day moving average price is $15.95 and its two-hundred day moving average price is $14.97.

A number of equities research analysts have issued reports on the stock. Zacks Investment Research downgraded shares of Signify Health from a “buy” rating to a “hold” rating in a research note on Friday, January 28th. Piper Sandler reduced their price target on shares of Signify Health from $34.00 to $27.00 and set an “overweight” rating on the stock in a research note on Sunday, March 6th. The Goldman Sachs Group raised their price target on shares of Signify Health from $20.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, March 21st. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Signify Health from $31.00 to $29.00 in a research note on Tuesday, January 25th. Finally, Guggenheim assumed coverage on shares of Signify Health in a research note on Tuesday, March 29th. They issued a “buy” rating and a $36.00 price target on the stock. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $25.70.

In other news, EVP Laurel Douty purchased 10,000 shares of the stock in a transaction on Wednesday, February 16th. The stock was purchased at an average price of $24.00 per share, for a total transaction of $240,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Geode Capital Management LLC grew its position in Signify Health by 2.0% in the 4th quarter. Geode Capital Management LLC now owns 422,049 shares of the company’s stock valued at $6,001,000 after purchasing an additional 8,380 shares during the period. Marshall Wace LLP acquired a new stake in Signify Health in the 4th quarter valued at $5,713,000. Parametric Portfolio Associates LLC grew its position in Signify Health by 70.7% in the 4th quarter. Parametric Portfolio Associates LLC now owns 241,870 shares of the company’s stock valued at $3,439,000 after purchasing an additional 100,142 shares during the period. Bank of New York Mellon Corp grew its position in Signify Health by 108.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 133,048 shares of the company’s stock valued at $2,378,000 after purchasing an additional 69,119 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Signify Health by 2.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 122,531 shares of the company’s stock worth $1,743,000 after acquiring an additional 2,726 shares during the last quarter.

About Signify Health (Get Rating)

Signify Health, Inc operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health.

Featured Articles

Receive News & Ratings for Signify Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Signify Health and related companies with MarketBeat.com's FREE daily email newsletter.